ZA200702374B - Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions - Google Patents

Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions

Info

Publication number
ZA200702374B
ZA200702374B ZA200702374A ZA200702374A ZA200702374B ZA 200702374 B ZA200702374 B ZA 200702374B ZA 200702374 A ZA200702374 A ZA 200702374A ZA 200702374 A ZA200702374 A ZA 200702374A ZA 200702374 B ZA200702374 B ZA 200702374B
Authority
ZA
South Africa
Prior art keywords
obesity
treatment
pharmaceutical compositions
diabetes mellitus
receptor antagonists
Prior art date
Application number
ZA200702374A
Other languages
English (en)
Inventor
Firnges Michael
Gregory Peter-Colin
Antel Jochen
Josephus Hubertus Maria Lange
Waldeck Harald
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of ZA200702374B publication Critical patent/ZA200702374B/xx

Links

ZA200702374A 2004-10-25 2005-10-25 Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions ZA200702374B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62107704P 2004-10-25 2004-10-25

Publications (1)

Publication Number Publication Date
ZA200702374B true ZA200702374B (en) 2009-05-27

Family

ID=38772169

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200702374A ZA200702374B (en) 2004-10-25 2005-10-25 Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions

Country Status (2)

Country Link
CN (1) CN101048153A (xx)
ZA (1) ZA200702374B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110246078A1 (en) * 2010-03-30 2011-10-06 Ye Fang Mitochondria katp ion channel as a drug target for preventing liver diseases and methods to screen mitochondria katp modulators

Also Published As

Publication number Publication date
CN101048153A (zh) 2007-10-03

Similar Documents

Publication Publication Date Title
IL176648A0 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
WO2007111864A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2007136577A3 (en) Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
WO2008008286A3 (en) Substituted pyrazoles as ghrelin receptor antagonists
WO2007109135A3 (en) Neuromedin u receptor agonists and uses thereof
WO2007003962A3 (en) Gpcr agonists
WO2007131219A3 (en) Cannabinoid receptor antagonists/inverse agonists
WO2005000820A3 (fr) Derives de 4-cyanopyrazole-3-carboxamide, leur preparation et leur application comme antagonistes des recepteurs aux cannabinoides cb1
WO2006042152A3 (en) Vasoactive intestinal polypeptide pharmaceuticals
WO2007076260A3 (en) Farnesoid x receptor agonists
WO2008051942A3 (en) Farnesoid x receptor agonists
IL219915A0 (en) Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
UA96308C2 (ru) Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение
EP1771188A4 (en) METHOD AND COMPOSITIONS FOR TREATING ADIPOSITAS, INSULINED DISEASES AND HYPERCHOLESTERINEMIA
WO2006047516A3 (en) Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
WO2006014618A3 (en) Substituted pyrazoles, compositions containing such compounds and methods of use
IL190110A (en) Cyclopropyline amines, pharmaceutical preparations containing them and their use as modulators for the histamine 3h receptor
WO2007104789A3 (en) Amylin derivatives
EP1782832A4 (en) MEANS FOR THE TREATMENT OF DIABETES
IL174693A0 (en) 3-(4-Aminophenyl)thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
EP1814550A4 (en) ANTAGONISTS OF N-SULFONYLPIPERIDINE CANNABINOID RECEPTOR 1
IL165499A (en) Vpac2 receptor agonist polypeptides, pharmaceutical compositions comprising them and uses thereof
WO2007120655A3 (en) Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
EP1625207A4 (en) COMPOUNDS FOR THE TREATMENT OF INFLAMMATION, DIABETES AND RELATED DISORDERS
WO2004005262A3 (en) New neuropeptide y y5 receptor antagonists